Search results
Google taps Eli Lilly finance chief as its new CFO
Quartz· 6 hours agoAfter almost a year of searching, Google parent Alphabet has finally found a replacement for its chief financial officer position. The tech giant has...
Viking says biopsy data confirm MASH drug’s benefit
BioPharma Dive via Yahoo Finance· 1 day agoWhile Madrigal launches that pill, which works the same way as VK2809, Viking is still years away from the market. The company is also now devoting...
Pre-Workout Side Effects: 5 Side Effects to Understand Before Starting It
MediaFeed via AOL· 8 hours agoIf you work out, you’ve probably heard about the slew of dietary supplements designed to boost...
Magic Pill
KTEP 88.5 El Paso· 3 days agoJohann elaborates how mental health is contributed with the food we intake and how these weight loss pills are truly horrible for your health. All these ...
Heard on the Street: Wall Street Is Cheering a New Obesity Pill Candidate. Here's Why.
The Wall Street Journal· 2 days agoYou don’t need a home run to get Wall Street excited about a pill for obesity. When the market...
Ozempic Maker Novo Nordisk Stock Up More Than 31% In 2024, But Is It Too Late To Buy Shares?
Investor's Business Daily· 5 days agoTheir primary weight-loss drugs are Wegovy and Zepbound, respectively. Both are taken through weekly...
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 5 days agoAstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as...
Structure Therapeutics Stock Soars on Obesity Pill Data
The Wall Street Journal· 2 days agoStructure’s once-daily drug, code-named GSBR-1290, helped people lose an average of more than 6% of...
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 6 days agoIn the first quarter, sales of weight-loss drug Zepbound skyrocketed and topped Wall Street's...
Heard on the Street: Wall Street Is Cheering a New Obesity Pill Candidate. Here's Why.
The Wall Street Journal· 2 days agoYou don’t need a home run to get Wall Street excited about a pill for obesity. When the market...